New Center Will Oversee Device Standards-Setting In China
This article was originally published in The Gray Sheet
A new Management Center for Medical Device Standards within China's State Food and Drug Administration will begin overseeing the formulation and revision of device standards
You may also be interested in...
SHANGHAI - China's State FDA recently unveiled its new Management Center for Medical Devices Standards in Beijing to oversee the drafting and revision of device standards
AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers
In the wake of Similis Bio’s first biosimilar partnership, the JSR Life Sciences unit’s head, John Gabrielson, talks to Generics Bulletin about the Similis Bio model and how the firm believes it can help bring biosimilars to market more rapidly and efficiently.